PRESS-RELEASE ·Filed Oct 22, 2026
Press release · Earnings
Price Chart
Loading chart...
Executive Summary
LENZ Therapeutics, Inc. announced it will report its Q3 2026 results on October 29, 2026.
Key Facts
- LENZ Therapeutics, Inc. announced it will report its Q3 2026 results on October 29, 2026.
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3386270 |
10 reports for LENZ
67% Hit rate @ T+1 Went positive at some point 2 of 3 best @ T+1▲ +4.15%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 5d ago | Press Release | $3.25 | awaiting T+1 | — | $3.15 (−3.08%) |
Oct 21, 2026 5d ago | SC 13G/A | $3.25 $3.16 | ▼ −2.77% | ▼ −2.25% | $3.15 (−3.08%) |
Aug 11, 2026 11w ago | Press Release | $5.04 $4.60 | ▼ −8.73% | ▼ −9.43% | $3.15 (−37.50%) |
Jul 2, 2026 16w ago | 8-K | $5.89 $5.60 | ▼ −4.92% | ▼ −5.80% | $3.15 (−46.52%) |
Jun 11, 2026 19w ago | Institutional Cluster | $6.50 $6.77 | ▲ +4.15% | ▲ +3.61% | $3.15 (−51.54%) |
Jun 7, 2026 20w ago | Press Release | $6.72 $6.79 | ▲ +1.04% | ▲ +1.34% | $3.15 (−53.12%) |
May 11, 2026 24w ago | 8-K | $7.91 $7.91 | · 0.00% | ▼ −0.54% | $3.15 (−60.18%) |
May 4, 2026 25w ago | Press Release | $9.28 $9.07 | ▼ −2.26% | ▼ −3.06% | $3.15 (−66.06%) |
Mar 24, 2026 31w ago | Press Release | $9.03 $9.07 | ▲ +0.44% | ▼ −0.12% | $3.15 (−65.12%) |
Feb 28, 2026 34w ago | Institutional Cluster | $13.68 $13.15 | ▼ −3.87% | ▼ −2.96% | $3.15 (−76.97%) |
Showing 10 of 10
US Market Status
Market Closed — Opens Wed (15h 55m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers